
NAMS P/E Ratio
P/E Ratio as of Jun 13, 2025: -10.76
Average-10.17
Median-10.11
Minimum-11.63
Maximum-9.06
-10.76
Past Month-0.80 (8.03%)
The P/E ratio for NAMS is -10.76 as of Jun 13, 2025. This represents a decrease of -83.71% compared to its 12-month average P/E ratio of -66.06. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Newamsterdam Pharma Co NV P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Newamsterdam Pharma Co NV’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Newamsterdam Pharma Co NV to industry peers.
Newamsterdam Pharma Co NV P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Newamsterdam Pharma Co NV’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Newamsterdam Pharma Co NV to industry peers.
NAMS P/E Ratio Insights
See Newamsterdam Pharma Co NV’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in NAMS
Order type
Buy in
Order amount
Est. shares
0 shares
NAMS P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $18.93 | -10.08 |
May 1, 2025 | $20.03 | -7.71 |
Apr 1, 2025 | $18.38 | -7.07 |
Mar 3, 2025 | $20.27 | -7.80 |
Feb 3, 2025 | $21.36 | -104.20 |
Jan 2, 2025 | $25.96 | -126.63 |
NAMS End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -10.76 | -91.42% |
2024 | -125.37 | +130.08% |
2023 | -54.49 | +2.48% |
2022 | -53.17 | -228.37% |
2021 | 41.42 | — |
FAQs About Newamsterdam Pharma Co NV (NAMS) P/E ratio
The latest P/E ratio of NAMS is -10.76, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Newamsterdam Pharma Co NV’s last 12-month average P/E ratio is -66.06, compared to its current P/E ratio of -10.76. This reflects a decrease of -83.71%.
Newamsterdam Pharma Co NV’s current P/E ratio of -10.76 is lower than its last 12-month average P/E of -66.06. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Newamsterdam Pharma Co NV’s average P/E ratio over the last 3 years is -55.87. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Newamsterdam Pharma Co NV’s average P/E ratio over the last 5 years is -24.74. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.